Associate Professor of Medicine, Emory University
Cardiology
Dr. Javed Butler, MD
|
|
Give Review
Javed Butler works in the field of Cardiology. He went to medical school at Aga Khan Medical College. He over the years received 3 awards: "Atlanta Magazine: Top Doctors", "Fellow (FACC)" and "Super Doctor". Doctor Javed Butler, MD is a published physician as well. He has 90 publications published. The latest was: Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association GetWithTheGuidelines-Heart Failure Registry. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Utility of Patient-Reported Outcome Instruments in Heart Failure.
- Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial).
- Contrasting Acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trial.
- Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions.
- Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.
- Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure.
- Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fract...
- Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy: Possible Modulating Effects of Paracrine Activities of Stem Cells.
- Prognostic significance of 123I-mIBG SPECT myocardial imaging in Heart failure: differences between patients with ischaemic and non-ischaemic Heart failure.
- Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
- Role of biomarkers in cardiac structure phenotyping in Heart failure with preserved ejection fraction: critical appraisal and practical use.
- Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device.
- In-hospital worsening Heart failure.
- Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials.
- The vulnerable phase after hospitalization for Heart failure.
- Changes in Serum Potassium Levels During Hospitalization in Patients With Worsening Heart Failure and Reduced Ejection Fraction (from the EVEREST Trial).
- Population Risk Prediction Models for Incident Heart Failure: A Systematic Review.
- Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor: Rationale and Design of the BLAST-AHF Study (Biased Ligand of the Angi...
- The Potential Role of Natriuretic Peptide-Guided Management for Patients Hospitalized for Heart Failure.
- Site selection for Heart failure clinical trials in the USA.
- Impact of diabetes on epidemiology, treatment, and outcomes of patients with Heart failure.
- Cardiac contractility modulation: the next cardiac resynchronization therapy or another renal sympathetic denervation?
- Get a move on Heart failure.
- Early management of patients with acute Heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/he...
- Resting Heart rate and risk of incident Heart failure: three prospective cohort studies and a systematic meta-analysis.
- Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction.
- Beta-Blocker Use and 30-Day All-Cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
- Oral Sodium and Potassium Binders in Heart Failure.
- Left atrium in Heart failure with preserved ejection fraction: structure, function, and significance.
- Comparative Assessment of Short-term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial.
- Advance Directives Among Hospitalized Patients With Heart Failure.
- Pharmacotherapy for Heart failure: the more we get to know, the more we need to know.
- Current Perspectives on Hydralazine and Nitrate Therapies in Heart Failure.
- Heart failure with normal ejection fraction, Heart failure with preserved ejection fraction, diastolic Heart failure, or huff-puff: time for a new taxonomy for hyperte...
- New Targets for Treating the Underlying Pathophysiology and Nonmotor Aspects of Parkinson's Disease.
- Mineralocorticoid Receptor Antagonist Use in Hospitalized Patients With Heart Failure, Reduced Ejection Fraction, and Diabetes Mellitus (from the EVEREST Trial).
- Global Perspectives in Hospitalized Heart Failure: Regional and Ethnic Variation in Patient Characteristics, Management, and Outcomes.
- Relation of Serum Uric Acid Levels and Outcomes Among Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressi...
- Recognizing worsening chronic Heart failure as an entity and an end point in clinical trials.
- Heart failure with preserved ejection fraction: a bouillabaisse.
- Spironolactone Use and Higher Hospital Readmission for Medicare Beneficiaries With Heart Failure, Left Ventricular Ejection Fraction <45%, and Estimated Glomerular Fil...
- Molecular and cellular basis of viable dysfunctional myocardium.
- Management of comorbid diabetes mellitus and worsening Heart failure.
- Hemoconcentration-Guided Diuresis in Heart Failure.
- Response to Sexton: inhibiting the Renin-Angiotensin-aldosterone system in patients with Heart failure and renal dysfunction: common sense or nonsense?
- Comorbid conditions in Heart failure: an unhappy marriage.
- Nitrite Therapy Improves Left Ventricular Function During Heart Failure via Restoration of Nitric Oxide-Mediated Cytoprotective Signaling.
- Developing Therapies for Heart Failure With Preserved Ejection Fraction: Current State and Future Directions.
- Site selection in global clinical trials in patients hospitalized for Heart failure: perceived problems and potential solutions.
- Strategies to reduce Heart failure readmissions--reply.
- Therapeutic Targets in Heart Failure: Refocusing on the Myocardial Interstitium.
- The Use of Digoxin in Patients with Worsening Chronic Heart Failure Reconsidering an Old Drug to Reduce Hospital Admissions.
- A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic Heart failure: targeting serum concentration to reduce hospit...
- Design of a Phase 2b Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Advanced Heart Failure: The CUPID 2 Trial (Calcium Up-Regulation by Percuta...
- The Global Health and Economic Burden of Hospitalizations for Heart Failure: Lessons Learned from HHF Registries.
- Adults with congenital Heart disease: growing pains.
- Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in Heart transplant recipients.
- The Prognostic Significance of Heart Rate in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in Sinus Rhythm: Insights From the EVEREST (Efficac...
- The immunological axis in Heart failure: importance of the leukocyte differential.
- Influence of Sex on Risk Stratification With Stress Myocardial Perfusion Rb-82 Positron Emission Tomography: Results From the PET (Positron Emission Tomography) Progno...
- Anticoagulation in Heart failure: current status and future direction.
- Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial.
- Need for increased awareness and evidence-based therapies for patients hospitalized for Heart failure.
- Atrial fibrillation and Heart failure: it takes two to tango.
- Relation of Serum Magnesium Levels and Postdischarge Outcomes in Patients Hospitalized for Heart Failure (from the EVEREST Trial).
- Progress or lack of progress in hospitalized Heart failure.
- Expanding the scope of the "polypill" to Heart failure.
- Classification of patients hospitalized for Heart failure.
- Recognizing hospitalized Heart failure as an entity and developing new therapies to improve outcomes: academics', clinicians', industry's, regulators', and payers' per...
- The potential role of nonpharmacologic electrophysiology-based interventions in improving outcomes in patients hospitalized for Heart failure.
- A world view of Heart failure requiring hospitalization. Foreword.
- Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for Heart failure with reduced ejection fraction: insights from the EVEREST...
- Nitrate Therapy for Heart Failure: Benefits and Strategies to Overcome Tolerance.
- Contemporary outcomes of optimally treated Heart failure patients with sleep apnea. Case for urgency in evaluation of newer interventions? From The Atlanta Cardiomyopa...
- Strategies and opportunities for drug development in Heart failure.
- Lack of evidence of increased mortality among patients with Atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
- Critical reappraisal of pulmonary artery catheterization and invasive hemodynamic assessment in acute Heart failure.
- Current management and future directions for the treatment of patients hospitalized for Heart failure with low blood pressure.
- Soluble guanylate cyclase: a potential therapeutic target for Heart failure.
- The disconnect between phase II and phase III trials of drugs for Heart failure.
- Relationship Between Clinical Trial Site Enrollment With Participant Characteristics, Protocol Completion, and Outcomes: Insights From the EVEREST (Efficacy of Vasopre...
- Endothelial dysfunction, arterial stiffness, and Heart failure.
- Primary prevention of Heart failure.
- Hospital Strategies to Reduce Heart Failure Readmissions: Where Is the Evidence?
- Incremental value of renal function in risk prediction with the Seattle Heart Failure Model.
- Utility of the Seattle Heart Failure Model in patients with advanced Heart failure.
- Patient-reported selective adherence to Heart failure self-care recommendations: a prospective cohort study: the Atlanta Cardiomyopathy Consortium.
- Use of hydralazine-isosorbide dinitrate combination in african american and other race/ethnic group patients with Heart failure and reduced left ventricular ejection f...
- The cardioprotective actions of hydrogen sulfide in acute myocardial infarction and Heart failure.
Schools
Aga Khan Medical College The Aga Khan University
Yale New Haven Hospital
Vanderbilt University
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Ectasia
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Bakery & Confectionary Union Plan
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- GHI PPO
- Empire Blue Cross Blue Shield HMO
- Prism Blue Priority EPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Choice Care PPO
- Kaiser Permanente
- MagnaCare PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
- Universal American
Awards
- Atlanta Magazine: Top Doctors
- Fellow (FACC)
- Super Doctor
Education
-
Vanderbilt University -
Yale-New Haven Hospital -
Aga Khan Medical College
Hospital
-
Stony Brook University Medical Center
Drug Facts
| NPI NUMBER | 1639100928 | |
| NPPES Provider LastName | BUTLER | |
| NPPES Provider FirstName | JAVED | |
| NPPES Provider ZIPCode | 117948167 | |
| NPPES Provider State | NY | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1459.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639100928 |
| Last Name Of The Provider | BUTLER |
| First Name Of The Provider | JAVED |
| View All |
Similar Doctors
|
Dr. Steven J. Eisenberg, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen D. Clements Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali R. Rahimi, MD |
|
|
Dr. George Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roy E. Abrahamian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mahmoud H. Abdou, MD |
|
|
Dr. Muhammad Hawasli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Patricia H. Raval, PA |
|
|
Dedra I. Blalock |
|
|
Robert A. Schwartz |